Trials / Completed
CompletedNCT01771913
Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts
Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts for Refinements of Reconstructed Breasts
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- Female
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate if there is a relationship between the take of fat grafts with and without ADSCs and the presence of specific surface markers on the cells of the stromal vascular fraction.
Detailed description
Two groups of patients will be studied. The control will receive centrifuged fat grafts while the other group will receive centrifuged enriched fat grafts with ADSCs. The performance of both grafts will be assessed through volume measurement employing MRI before and after 6 months post-op.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | centrifuged fat graft | fat from the abdominal subcutaneous tissue will be taken by vacuum assisted lipectomy and immediately prepared to be grafted in the reconstructed breast that presents contour irregularities and/or volume insufficiency. No adipose derived stem cells will enrich the fat grafts in this group. |
| GENETIC | ADSCs enriched fat graft | fat from the abdominal subcutaneous tissue will be taken by suction assisted lipectomy and stromal vascular fraction will be isolated and immediately added to the fat graft that will be employed to improve contour irregularities and volume insufficiency of reconstructed breasts. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-09-01
- Completion
- 2015-05-01
- First posted
- 2013-01-18
- Last updated
- 2015-08-24
- Results posted
- 2015-08-24
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01771913. Inclusion in this directory is not an endorsement.